Results 131 to 140 of about 1,183,167 (309)
This graphical abstract illustrates the effects of myo‐inositol supplementation during suckling in reducing long‐term metabolic impacts from mild gestational calorie restriction (GCR). Using a metabolomics approach, 164 metabolites were identified, with greater metabolic alterations in males.
Rocío A. Martín‐Chamorro +6 more
wiley +1 more source
Abstract In March of 2025, 145 attendees convened at the Hub for Clinical Collaboration of the Children's Hospital of Philadelphia for the inaugural International Society for Magnetic Resonance in Medicine (ISMRM) Body MRI Study Group workshop entitled “Body MRI: Unsolved Problems and Unmet Needs.” Approximately 24% of the attendees were MD or MD/PhD's,
Elizabeth M. Hecht +9 more
wiley +1 more source
ABSTRACT The presence of excess weight is no longer a distinguishing feature between patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D). Obesity treatment in patients with T2D improves glycemic control and reduces or even eliminates medication burden.
Kathleen R. Ruddiman +2 more
wiley +1 more source
ABSTRACT Objective From October 18 to 20, 2022, the National Institutes of Health held a workshop to examine the state of the science concerning obesity interventions in adults to promote health equity. The workshop had three objectives: (1) convene experts from key institutions and the community to identify gaps in knowledge and opportunities to ...
Loneke T. Blackman Carr +26 more
wiley +1 more source
Application of machine learning in constructing a diagnostic model for neonatal biliary atresia
This study included 85 neonates who visited the hospital due to pathological jaundice. Using the basic clinical characteristics and serological examination data of the neonatal period, we developed six machine‐learning (ML) models. Extreme gradient boosting has the maximum potential to diagnose biliary atresia in the neonatal period.
Dingding Wang +11 more
wiley +1 more source
ABSTRACT Given the high prevalence of the population who have metabolic dysfunction‐associated steatohepatitis (MASH), interest is growing in MASH‐targeted treatments. However, currently, there has been only one regulatory approved drug for MASH (Rezdiffra).
Quyen Thi Tran +11 more
wiley +1 more source
The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver disease. [PDF]
Møller S +5 more
europepmc +1 more source
ABSTRACT Background and Aims The European Reference Network on Hepatological Diseases (ERN RARE‐LIVER) is a Europe‐wide network for centers of excellence in the management of rare liver diseases. We aimed to evaluate the current diagnostic and therapeutic trends of primary biliary cholangitis (PBC).
A. Gerussi +23 more
wiley +1 more source
Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure. [PDF]
Taru V +11 more
europepmc +1 more source
Abstract This report describes the diagnosis, treatment and long‐term follow‐up of a dog with hepatic arteriovenous malformation and extensive thrombus of the splanchnic vessels. A 1‐year‐old, male, neutered golden retriever presented with haematochezia and ascites.
Yuqing Sun +2 more
wiley +1 more source

